bluebird bio

$BLUE macht langsam auch wieder Fortschritte

CMS enters agreement with Vertex ($VRTX (-0,44 %) ), bluebird to improve access to gene therapies

https://www.reuters.com/business/healthcare-pharmaceuticals/cms-enters-agreement-with-vertex-bluebird-improve-access-gene-therapies-2024-12-04/